Results 121 to 130 of about 34,399 (185)

Polypoidal Choroidal Vasculopathy

Ophthalmology Retina
Min Wang, Simon S. Gao, Yali Jia
  +4 more sources

Predictors of response to bevacizumab monotherapy in polypoidal choroidal vasculopathy: a 12-month retrospective study. [PDF]

Int J Retina Vitreous
Montrisuksirikun C, Pongrujikorn S, Rodanant N, Thoongsuwan S, Prakhunhungsit S, Wongchaisuwat N, Phasukkijwatana N.   +6 more
europepmc   +1 more source

REGIONAL VARIABILITY IN CHOROIDAL VASCULARITY INDEX AND ASSOCIATION WITH INTERVORTEX ANASTOMOSES IN POLYPOIDAL CHOROIDAL VASCULOPATHY. [PDF]

Retina
Chong YJ, Chong Teo KY, Gilead N, Akiba M, Cheung CMG.   +4 more
europepmc   +1 more source

Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab. [PDF]

J Clin Med
Spindler J, Pfister IB, Weinberger A, Garweg JG.   +3 more
europepmc   +1 more source

Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]

PLoS One
Yoshinaga A, Kitamoto K, Aoki S, Terao R, Inoue T, Obata R, Azuma K.   +6 more
europepmc   +1 more source

Management of Polypoidal choroidal vasculopathy and diabetic retinopathy: Practice patterns amongst vitreoretinal surgeons of India-A VRSI survey. [PDF]

Indian J Ophthalmol
Sindal MD, Mahendrakar P, Kothari A, Tyagi M, Mishra D, Tagare S, Vaidya M, Shanmugam M.   +7 more
europepmc   +1 more source

Recognition and treatment of polypoidal choroidal vasculopathy and age-related macular degeneration in British Columbia. [PDF]

Int J Retina Vitreous
Lee Y, Rahman S, Tao BK, Fang T, Akil H, Ferrara D, Lam S, Navajas EV.   +7 more
europepmc   +1 more source

The <i>CFH-CFHR5</i> Locus in Wet Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy, and Central Serous Chorioretinopathy. [PDF]

Ophthalmol Sci
Chen ZJ, Yu J, Ho M, Ng DSC, Brelen ME, Young AL, Yam JCS, Tham CC, Pang CP, Chen LJ.   +9 more
europepmc   +1 more source

Combined Therapy Versus Fortified Anti-VEGF Monotherapy in Type C Polypoidal Choroidal Vasculopathy: Long-Term Outcomes and Exploratory Biomarker Insights. [PDF]

Int J Mol Sci
Chao WW, Chao HW, Chao HM.
europepmc   +1 more source

Polypoidal Choroidal Vasculopathy: From Clinicopathological and Molecular Perspectives.

Ophthalmic Res
Zhang C, Zhang W, Wang T, Wen L, Zhang J.   +4 more
europepmc   +1 more source